The role of CD4+ T cell responses in antitumor immunity
β Scribed by Drew M Pardoll; Suzanne L Topalian
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 630 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0952-7915
No coin nor oath required. For personal study only.
β¦ Synopsis
While most of the focus in cancer immunology is on CD8+ cytotoxic T lymphocyte responses, recent evidence indicates that CD4+ T cells are an equally critical component of the antitumor immune response. Successful immunity to cancer will therefore require activation of tumor-specific CD4+ T cells. Tumor antigens recognized by CD4+ T cells that are restricted by MHC class II are beginning to be defined in both murine and human tumors. These will provide the basis for new generations of antigen-specific tumor vaccines.
π SIMILAR VOLUMES
CD4, CD8 and CD45 regulate the coupling of the T-cell receptor complex (CD3-TCR) to tyrosine kinase activation and phosphorylation of key substrates such as phospholipase C gamma 1. CD4 and CD8 contribute to activation signals through their cytoplasmic association with p56lck. Expression of the zeta
## Abstract TNFRSF25 is a member of the TNF receptor superfamily (TNFRSF) that binds to the TNFβlike protein TL1A. Although recent studies have demonstrated a role for TNFRSF25 in regulating CD4^+^ Tβcell responses, it remains to be determined if TNFRSF25 functions as a costimulatory receptor for C